Galectin-3 plays an important role in endometriosis development and is a target to endometriosis treatment

Rômulo Medina de Mattos, Mattos RM, Daniel Escorsim Machado, Machado DE, Jamila Alessandra Perini, Jéssica Alessandra-Perini, Alessandra-Perini J, Meireles da Costa NO, Nathália de Oliveira Meireles da Costa, Adalgisa Felippe da Rocha de Oliveira Wiecikowski, Adalgisa Felippe Wiecikowski, Wiecikowski AFDRO, Kátia Maria dos Santos Cabral, Katia Maria Dos Santos Cabral, Cabral KMDS, Christina Maeda Takiya, Carvalho RS, Renato Sampaio Carvalho, Renato S. Carvalho, Nasciutti LE, Luiz Eurico Nasciutti
Molecular and cellular endocrinology · 2019 · vol. 486 , pp. 1–10 · doi:10.1016/j.mce.2019.02.007 · PMID:30753853 · W2913150157
Lab / animal OA: closed CC0 ⤵ 15 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-10 ⓘ

Galectin-3 deficiency and Gal-3 carbohydrate recognition domain treatment reduced endometriotic lesion size, vascularization, and macrophage infiltration in mice.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This study aimed to analyze galectin-3 importance in endometriotic lesions development and the effect of recombinant Gal-3 carbohydrate recognition domain (Gal3C) in experimental endometriosis treatment. Experimental endometriosis was induced in WT and Gal-3-/- mice. Initially developed lesions were macroscopically and histologically analyzed, including immunohistochemical analysis. Then, WT mice were treated with Gal3C for 15 days. Gal-3 deficiency and Gal3C treatment significantly impaired endometriosis development. A significant decrease in lesions implantation and size, VEGF and VEGFR-2 expression, vascular density and macrophage distribution were observed in Gal-3 absence or inhibition. A greater presence of iNOS positive cells was observed in knockout mice lesions, while the presence of Arginase positive cells was higher in the WT animal lesions. In addition, COX-2 and TGFb1 were reduced by Gal3C treatment. Data showed here indicate a relevant role of Gal-3 in endometriosis development and highlight a target of endometriosis treatment using Gal-3 inhibitor.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Galectin 3 Molecular Targeted Therapy Molecular Targeted Therapy Animals Animals Biomarkers Biomarkers Biomarkers Endometriosis Endometriosis Endometrium Endometrium Endometrium Endometrium Female Female Galectin 3 Galectin 3

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (53)

Cited by (17)

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:23:58.330360+00:00
License: CC0 · commercial use OK